Analyst consensus rating
NRX Pharmaceuticals Analyst Rating: Strong Buy
Direct answer
NRX Pharmaceuticals's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $38.75.
Forecast evidence checked November 14, 2026.
Get free NRX Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.19
- Average price target
- $38.75
- High price target
- $51.00
- Low price target
- $10.00
- Low target gap
- +356.6%
- Target upside
- +1,669.4%
- High target gap
- +2,228.8%
- Target range width
- 1,872.1%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for NRX Pharmaceuticals?
NRX Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $38.75.
How far are NRX Pharmaceuticals's low and high targets from the recorded price?
The low target implies +356.6%, while the high target implies +2,228.8%.
How many analysts are included in NRX Pharmaceuticals's consensus?
The verified consensus includes 4 analysts.
How is NRX Pharmaceuticals's target upside or downside calculated?
The average target of $38.75 is divided by the recorded price of $2.19, then one is subtracted to produce +1,669.4%. This does not guarantee a future return.
When was NRX Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.